New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors
A subset of patients with IBD may have latent susceptibility to AD, unmasked by therapy cessation and potentially triggered by an immune rebound effect.
Authors
- Christopher R. Shea (ORCID: https://orcid.org/0000-0002-3780-8113)
- David Choi (ORCID: https://orcid.org/0000-0002-2453-1784)
- Benjamin D. McDonald (ORCID: https://orcid.org/0000-0003-1308-8788)
- David T. Rubin (ORCID: https://orcid.org/0000-0001-5647-1723)
- Russell Yanofsky (ORCID: https://orcid.org/0000-0001-9313-6422)
- Newsha Nikzad (ORCID: https://orcid.org/0000-0001-8447-8527)
- Angad Chadha (ORCID: https://orcid.org/0000-0001-7986-3244)
Institutions
- University of Chicago (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2025-08-22
- DOI
- https://doi.org/10.14309/ajg.0000000000003742
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00